For Jessie Devillier, the path to becoming an occupational therapist wasn’t straightforward — but it was the right choice.

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is conducting a ...

They urge people to be wary of misinformation, like false claims on social media posts that hormones will prevent dementia ...

In this video from the American Society of Retina Specialists annual meeting, Charles C. Wykoff, MD, PhD, FASRS, discusses ...

Health Canada grants marketing approval to Roche’s Columvi for R/R diffuse large B-cell lymphoma after initial therapy: Mississauga, Canada Saturday, August 23, 2025, 17:00 Hrs ...

I maintain a Strong Buy on Krystal Biotech, as the pause in melanoma trial enrollment is offset by promising progress in ...

"Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since ...

Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

Researchers found that adding a third immune-targeting drug to existing therapies helped shrink tumors in lab models of ...

Early results from the TUSCANY trial highlight promising remission rates and safety for a new triplet therapy in treating ...

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy ...